Major Scope

  •  Colon and Rectal Surgery
  •  General Surgery
  •  Gynecologic Oncology
  •  Plastic Surgery
  •  Neurological Surgery
  •  Orthopaedic Surgery
  •  Orthopaedic Surgery of the Spine
  •  Neonatal Surgery
  •  Prenatal Surgery
  •  Trauma Surgery
  •  Surgical Intensivists, Specializing In Critical Care Patients
  •  Thoracic Surgery
  •  Congenital Cardiac Surgery
  •  Thoracic Surgery-Integrated
  •  Vascular Surgery

Abstract

Citation: Clin Surg. 2021;6(1):3084.Research Article | Open Access

Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy

Boualaoui I*, Bey E, De Villeneuve MH, Dergamoun H, Droupy S and Wagner L

Department of Urology and Andrology, Nimes University Hospital Center, France

*Correspondance to: Boualaoui I 

 PDF  Full Text DOI: 10.25107/2474-1647.3084

Abstract

Introduction: AirSeal? is an insufflation system that enables a stable pneumoperitoneum during laparoscopic surgery, thus providing a permanent renewal of the abdominal gas in a closed system. The aim of this study was to evaluate the medical and economic impact of the AirSeal? system for laparoscopic sacrocolpopexy. Materials and Methods: A preliminary mono-centric retrospective study has been performed during a period of 9 months between May 2019 and February 2020. Post-operative pain was evaluated by a visual analog scale on days 0, 1, and 2. Analgesic and antiemetic use was also collected. The main intraoperative anesthesiologic parameters (morphine and curare doses, peak airways pressure, endtidal CO2 , and temperature) were also studied. The patient?s outing ability was evaluated by the CHUNG score. Results: Thirty-four consecutive patients treated by laparoscopic sacrocolpopexy have been included in the present study. The first 17 were operated using the AirSeal? system and the other half using a standard insufflating system, by the same surgeon. Mean age was 58.9 ? 12.2 years. Postoperative pain was lower in the AirSeal? system group with 40% of morphinic use vs. 52% in the standard system group. The length of stay was also shorter, with 65% of AirSeal? system patients able to leave on an ambulatory basis vs. 35% in the second group, and 95% on first day vs. 76% in the standard insufflation system group. Conclusion: These preliminary results may suggest a positive medical and economic impact of the AirSeal? insufflation system by reducing length of stay, postoperative pain and analgesic use.

Keywords

Sacrocolpopexy; Low impact laparoscopy; laparoscopy; Postoperative pain

Cite the article

Boualaoui I, Bey E, De Villeneuve MH, Dergamoun H, Droupy S, Wagner L. Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy. Clin Surg. 2021; 6: 3084.

Journal Basic Info

  • Impact Factor: 2.395**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
  • NLM ID: 101702548

Search Our Journal

Journal Indexed In

Articles in PubMed

Mesh Sprayer Device with Liquefied Mesh Delivery System: Proposed Alternative for Currently Available Meshes in Hernia Repair and Supplement to Abdominal Closure
 PubMed  PMC  PDF  Full Text
RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Os Odontoideum as a Cause of Cervical Cord Injury in a Patient with Refractory Epilepsy
 Abstract  PDF  Full Text
Use of Accessible Blood Filter for Postoperative Cell Salvage in Cardiac Surgery
 Abstract  PDF  Full Text
View More...